Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/2614
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hamurtekin, Emre | - |
dc.contributor.author | Hamurtekin, Y. | - |
dc.contributor.author | Matucci, R. | - |
dc.contributor.author | Dei, S. | - |
dc.contributor.author | Dayanç, Barış Emre | - |
dc.contributor.author | Kazdağlı, Hasan | - |
dc.date.accessioned | 2023-06-16T14:46:38Z | - |
dc.date.available | 2023-06-16T14:46:38Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 1811-7775 | - |
dc.identifier.issn | 1812-5700 | - |
dc.identifier.uri | https://doi.org/10.3923/ijp.2022.1429.1439 | - |
dc.identifier.uri | https://hdl.handle.net/20.500.14365/2614 | - |
dc.description.abstract | Background andObjective: Hypericum perforatum L (HP) is a popular herbal medicine with different pharmacological effects. This study investigated the possible cholinergic receptor affinities of HP extract and its three active constituents: hyperforin, hypericin and pseudohypericin. Materials and Methods: Radioactive compounds [3H]-N-methyl scopolamine used for muscarinic receptor binding studies in Chinese hamster ovary cells expressing human muscarinic receptor subtypes and [3H]-cytisine used for nicotinic receptor binding tests performed with mouse brains without a cerebellum. Muscarinic binding inhibition was observed with HP extract considerably for hM2 and hM5. Results: Hyperforin, hypericin and pseudohypericin showed a much lower affinity for muscarinic receptors at higher concentrations. The HP extract and its constituents did not produce any nicotinic receptor binding inhibition. Conclusion:These results suggested that post-junctional direct muscarinic receptor interaction may modulate some effects of HP extract and its constituents however different mechanisms apart from direct cholinergic receptor interaction might be considered for the pharmacological actions of hyperforin, hypericin and pseudohypericin. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Asian Network Scientific Information-Ansinet | en_US |
dc.relation.ispartof | Internatıonal Journal of Pharmacology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Hypericum perforatum L. | en_US |
dc.subject | muscarinic receptors | en_US |
dc.subject | nicotinic receptors | en_US |
dc.subject | hyperforin | en_US |
dc.subject | hypericin | en_US |
dc.subject | pseudohypericin | en_US |
dc.subject | St-Johns-Wort | en_US |
dc.subject | Acetylcholine-Release | en_US |
dc.subject | Hyperforin | en_US |
dc.subject | Mechanism | en_US |
dc.subject | Reveals | en_US |
dc.subject | Extract | en_US |
dc.subject | Bladder | en_US |
dc.subject | Memory | en_US |
dc.subject | Drug | en_US |
dc.title | Cholinergic Receptor Binding Profile of Hypericum perforatum L. and its Active Constituents | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.3923/ijp.2022.1429.1439 | - |
dc.department | İzmir Ekonomi Üniversitesi | en_US |
dc.authorid | Dei, Silvia/0000-0003-0898-7148 | - |
dc.identifier.volume | 18 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.startpage | 1429 | en_US |
dc.identifier.endpage | 1439 | en_US |
dc.identifier.wos | WOS:000871581300010 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopusquality | N/A | - |
dc.identifier.wosquality | Q4 | - |
item.grantfulltext | open | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 09.01. Basic Medical Sciences | - |
crisitem.author.dept | 15.02. Elderly Care | - |
Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
Page view(s)
92
checked on Nov 18, 2024
Download(s)
30
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.